Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury

Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury

The full-length receptor for advanced glycation end products (RAGE) is a multiligand pattern recognition receptor. High-mobility group box 1 (HMGB1) is a RAGE ligand of damage-associated molecular patterns that elicits inflammatory reactions. The shedded isoform of RAGE and endogenous secretory RAGE...

Full description

Bibliographic Details
Main Authors:	Taro Miyagawa, Yasunori Iwata, Megumi Oshima, Hisayuki Ogura, Koichi Sato, Shiori Nakagawa, Yuta Yamamura, Yasutaka Kamikawa, Taito Miyake, Shinji Kitajima, Tadashi Toyama, Akinori Hara, Norihiko Sakai, Miho Shimizu, Kengo Furuichi, Seiichi Munesue, Yasuhiko Yamamoto, Shuichi Kaneko, Takashi Wada
Format:	Article
Language:	English
Published:	The Company of Biologists 2022-01-01
Series:	Biology Open
Subjects:	receptor for advanced glycation end products (rage) soluble receptor for advanced glycation end products (srage) ischemia and reperfusion acute kidney injury high-mobility group box 1 (hmgb1)
Online Access:	http://bio.biologists.org/content/11/1/bio058852

Similar Items

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
by: Eva O. Melin, et al.
Published: (2020-10-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant
by: Ingrid Fricke-Galindo, et al.
Published: (2024-04-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
by: Sára Csiha, et al.
Published: (2023-05-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

RAGE Signaling in Melanoma Tumors
by: Olamide T. Olaoba, et al.
Published: (2020-11-01)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
by: Mieke Steenbeke, et al.
Published: (2022-03-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Receptor of advanced glycation end product (RAGE) polymorphism and oxidative status in Hashimoto’s thyroiditis in Egyptian female patients: case control study
by: Noura Mostafa Mohamed, et al.
Published: (2022-05-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
by: Elena Dozio, et al.
Published: (2020-12-01)

Inhibitory Effects of <i>Saururus chinensis</i> Extract on Receptor for Advanced Glycation End-Products-Dependent Inflammation and Diabetes-Induced Dysregulation of Vasodilation
by: Kenjiro Hayashi, et al.
Published: (2022-05-01)

RAGE is a critical factor of sex-based differences in age-induced kidney damage
by: Seerat Bajwa, et al.
Published: (2023-03-01)

The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
by: Sarah Louise Fishman, et al.
Published: (2018-11-01)

HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets
by: Petra Tesarova, et al.
Published: (2016-03-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts
by: Bradley A. Krisanits, et al.
Published: (2022-03-01)

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
by: Nordin M. J. Hanssen, et al.
Published: (2020-09-01)

Humoral factors in the formation of neuroosteoarthropathy in type 2 diabetes mellitus
by: M. M. Kalandiya, et al.
Published: (2023-12-01)

Biomarkers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Active Nephritis
by: Lu Liu, et al.
Published: (2023-08-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
by: Franziska Diekmann, et al.
Published: (2021-08-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
by: Xiaoyan Zhou, et al.
Published: (2018-02-01)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01)

The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
by: Niki L. Reynaert, et al.
Published: (2023-05-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview
by: Pedreanez Adriana, et al.
Published: (2024-01-01)

Do advanced glycation end products contribute to food allergy?
by: P. K. Smith, et al.
Published: (2023-04-01)

The Prolonged Activation of the p65 Subunit of the NF-Kappa-B Nuclear Factor Sustains the Persistent Effect of Advanced Glycation End Products on Inflammatory Sensitization in Macrophages
by: Sayonara Ivana Santos de Assis, et al.
Published: (2024-02-01)

S100B Impairs Oligodendrogenesis and Myelin Repair Following Demyelination Through RAGE Engagement
by: Gisela Santos, et al.
Published: (2020-09-01)

Sputum–plasma ratio of soluble receptor for advanced glycation end-products in patients with chronic obstructive pulmonary disease
by: Essam Gouda Hassanein, et al.
Published: (2016-07-01)

Detection of receptor for advanced glycation end products (RAGE) and high mobility group protein box 1 HMGB1 levels in patients’ serum with breast cancer
by: Hind Shawqi Zaki, et al.
Published: (2023-01-01)

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
by: Seigmund Wai Tsuen Lai, et al.
Published: (2024-01-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)